Pro Medicus Sustainability Profile
Pro Medicus Limited, commonly referred to as Pro Medicus, is a leading provider of radiology information systems and imaging software solutions, headquartered in Australia. Established in 1983, the company has made significant strides in the healthcare technology sector, particularly in the fields of medical imaging and radiology. With a strong presence in Australia, North America, and Europe, Pro Medicus has positioned itself as a key player in the industry. The company’s core offerings include advanced imaging solutions that enhance workflow efficiency and improve patient care. Pro Medicus is renowned for its unique cloud-based platform, which allows for seamless integration and accessibility across various healthcare settings. Notable achievements include partnerships with major healthcare institutions and a consistent track record of innovation, solidifying its market position as a trusted provider in the healthcare technology landscape.
DitchCarbon Score
How does Pro Medicus's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Pro Medicus's score of 29 is higher than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Pro Medicus's reported carbon emissions
In 2024, Pro Medicus, headquartered in Australia, reported total carbon emissions of approximately 1,506,000 kg CO2e. This figure includes 1,900 kg CO2e from Scope 1 emissions, 118,900 kg CO2e from Scope 2 emissions, and a significant 1,385,000 kg CO2e from Scope 3 emissions. In comparison, the previous year, 2023, the company recorded total emissions of about 1,454,000 kg CO2e, with similar Scope 1 and Scope 2 figures of 1,900 kg CO2e and 96,700 kg CO2e, respectively, and 1,355,000 kg CO2e from Scope 3. Pro Medicus has not set specific reduction targets or initiatives as part of their climate commitments, nor do they participate in the Science Based Targets initiative (SBTi). The company’s emissions data is not cascaded from any parent organization, indicating that all reported figures are directly from Pro Medicus Limited. Overall, Pro Medicus's emissions profile highlights a substantial reliance on Scope 3 emissions, which typically encompass indirect emissions from the value chain, suggesting an area for potential focus in future sustainability efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 1,900 | 0,000 | 0,000 | 0,000 |
| Scope 2 | 125,100 | 000,000 | 00,000 | 000,000 |
| Scope 3 | - | - | 0,000,000 | 0,000,000 |
How Carbon Intensive is Pro Medicus's Industry?
How Carbon Intensive is Pro Medicus's Location?
Pro Medicus's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Pro Medicus has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
